Prospective OCT Study With Lucentis for Neovascular AMD (PrONTO Study)
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
The PrONTO Study was designed to evaluate the response of neovascular age-related macular
degeneration (AMD) patients to intravitreal Lucentis using Optical Coherence Tomography (OCT)
imaging. OCT was then used to determine the need for retreatment after 3 monthly injections
of Lucentis. Patients would be followed for 2 years.